356 results on '"Clarke, Callisia N."'
Search Results
2. Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative
3. ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms
4. Evolution of Surgical Management and Outcomes of Neuroendocrine Tumor Liver Metastases
5. Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy
6. Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy
7. CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
8. Assessing the Complex General Surgical Oncology Pipeline: Trends in Race and Ethnicity Among US Medical Students, General Surgery Residents, and Complex General Surgical Oncology Trainees
9. ASO Visual Abstract: Neighborhood Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy
10. Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer
11. Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice
12. Severity of Prior Coronavirus Disease 2019 is Associated With Postoperative Outcomes After Major Inpatient Surgery
13. Severity of Prior COVID-19 is Associated with Postoperative Outcomes Following Major Inpatient Surgery
14. Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative
15. Roses & Thorns of Academic Surgery: Demystifying the Journey with Dr. Callisia Clarke
16. Disparities in Mentorship and Implications for US Surgical Resident Education and Wellness
17. Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care
18. ASO Visual Abstract: Assessing the Complex General Surgical Oncology Pipeline–Trends in Race and Ethnicity Among US Medical Students, General Surgery Residents, and Complex General Surgical Oncology Trainees
19. Advancement and Leadership Development
20. Disparities in Creating a Diverse Surgical Oncology Physician Workforce: Just a Leaky Pipeline?
21. ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer
22. Epidemiology and risk factors for metastatic colorectal disease
23. Contributors
24. Can I Leave? Perspectives on Parental Leave and Parenthood in Medical Training Among Program Directors and Trainees in Oncologic Specialties
25. The History of Isolated Hepatic Perfusion for Liver Metastases and Current Indications for Use
26. Surgical Societies Must Lead the Way on Addressing Bias and Microaggressions
27. Total Neoadjuvant Therapy for Operable Pancreatic Cancer
28. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer
29. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma
30. Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database
31. Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series.
32. Treatment Sequencing for Borderline Resectable Pancreatic Cancer
33. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer
34. Commentary on Brief Clinical Report: “Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreaticoduodenectomy: A pilot series”
35. Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy
36. Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
37. Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma
38. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms
39. Molecular Markers and Mutational Analysis
40. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery
41. Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
42. Distal splenorenal and mesocaval shunting at the time of pancreatectomy
43. Advancement and Leadership Development
44. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages
45. Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.
46. Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer
47. The History of Isolated Hepatic Perfusion for Liver Metastases and Current Indications for Use
48. The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network
49. Minimally invasive hepatectomy conversions: an analysis of risk factors and outcomes
50. Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.